Table 1. Multivariate Cox regression including the 40-gene test and breast cancer clinical variables.
Variable | HR1 | 95% CI2 | p-val | |
40-gene test | H vs L | 4.43 | 2.46 to 7.95 | 8.5×10−8 * |
I vs L | 2.06 | 1.13 to 3.74 | 6.7×10−7 * | |
tumor size (T2 vs T1) | 2.21 | 1.52 to 3.21 | 3.0×10−5 * | |
Node (positive vs negative) | 1.07 | 0.78 to 1.46 | 0.69 | |
ER status (negative vs positive) | 1.15 | 0.77 to 1.72 | 0.50 | |
Grade (3 vs 1 and 2) | 1.00 | 0.72 to 1.41 | 0.98 | |
Age (≤50 vs >50, years) | 1.27 | 0.82 to 1.97 | 0.28 |
Total number of samples is 668. Endpoint analyzed was distant metastasis at 10 years.
Cox analysis was done stratifying by dataset.
HR: Hazard ratio.
CI: confidence interval.
Significant p-values.